Tue.Jun 11, 2024

article thumbnail

Europe taps CSL Seqirus to produce bird flu vaccines for pandemic preparedness efforts

Fierce Pharma

Right after signing on to help with bird flu pandemic preparedness efforts in the U.S., CSL Seqirus has agreed to do the same in Europe through a vaccine supply pact. | The vaccine maker will deliver 665,000 doses of its avian flu-matched pre-pandemic vaccine. Under a 4-year contract, authorities can purchase up to 40 million doses.

328
328
article thumbnail

How Regulatory Ambiguity is Impeding Healthcare Innovation

MedCity News

America should be a global leader in healthcare. Instead, we rank last among our peers, and outmoded regulations are holding us back. The post How Regulatory Ambiguity is Impeding Healthcare Innovation appeared first on MedCity News.

article thumbnail

After M&A stretch, Pfizer CEO says company needs 'breathing period' from large deals

Fierce Pharma

Amid a recent biopharma M&A resurgence, one major player plans to stay out of the waters after making multiple recent splashes. | Though not for lack of business development capacity, Pfizer is currently taking a large dealmaking “breathing period,” CEO Albert Bourla told investors this week at Goldman Sachs’ 2024 annual Global Healthcare Conference in Miami.

Biopharma 265
article thumbnail

Ipsen, Genfit Drug That Missed in MASH Wins FDA Approval in a Much Rarer Liver Disease

MedCity News

Iqirvo failed as a treatment for the fatty liver disease MASH, but the drug is now FDA approved in primary biliary cholangitis. An Intercept Pharmaceuticals drug already treats this rare liver disease and Gilead Sciences is poised to compete with its PBC drug approaching an FDA decision this summer. The post Ipsen, Genfit Drug That Missed in MASH Wins FDA Approval in a Much Rarer Liver Disease appeared first on MedCity News.

FDA 120
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

Gilead forks over $40M to settle thousands of claims in web of litigation over alleged delay of safer HIV meds

Fierce Pharma

As Gilead Sciences awaits the progression of California state litigation over its alleged delay of safer HIV drugs, the company is biding its time with a proposed $40 million settlement t | More than 2,000 plaintiffs accused the HIV drugmaker of purposely waiting to launch safer TAF-based meds in the early 2000s in order to maximize profits from its older TDF-based products.

242
242
article thumbnail

Report: MA Beneficiaries Spend $2,500 Less on Healthcare Than Traditional Medicare Beneficiaries

MedCity News

A report conducted by ATI Advisory and commissioned by Better Medicare Alliance found that Medicare Advantage beneficiaries have lower healthcare spending than fee-for-service Medicare enrollees. This is true across racial and ethnic groups, according to the report. The post Report: MA Beneficiaries Spend $2,500 Less on Healthcare Than Traditional Medicare Beneficiaries appeared first on MedCity News.

More Trending

article thumbnail

Navigating the Tricky Climate of Health Tech Funding

MedCity News

Getting would-be investors—and the right kind of investors—to notice and care about your company requires a robust strategy. The post Navigating the Tricky Climate of Health Tech Funding appeared first on MedCity News.

119
119
article thumbnail

Ipsen, Genfit gain FDA approval for Iqirvo in liver disorder, teeing up Intercept showdown

Fierce Pharma

Once hyped as a potential blockbuster medicine for metabolic-associated steatohepatitis (MASH), Ipsen and Genfit’s elafibranor has found its calling as a treatment for a lower-profile liver disorde | Once hyped as a potential blockbuster medicine for metabolic-associated steatohepatitis (MASH), Ipsen and Genfit’s elafibranor has found its calling as a treatment for a lower-profile liver disorder.

Medicine 200
article thumbnail

New polymer-based drug delivery system developed for tuberculosis

European Pharmaceutical Review

Researchers have reported the successful formulation of clofazimine spray-dried poly (lactic acid-co-glycolic acid) (PLGA) microparticles as an “efficient” treatment for tuberculosis (TB). In treating this bacterial infection, the paper highlighted that oral therapy often fails to achieve therapeutic concentrations at the primary infection site, the lungs.

article thumbnail

Ahead of UK election, life sciences trade group pushes politicians to boost local industry

Fierce Pharma

As the U.K. braces for a potential government shake-up ahead of its general election next month, the country’s premier biopharma trade organization is throwing down the gauntlet. | The Association of the British Pharmaceutical Industry is challenging U.K. political parties to blueprint their plans to unlock the nation’s healthcare industry potential, according to a press release issued Monday.

Biopharma 182
article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Lilly’s Alzheimer’s drug set to join Leqembi after FDA vote

pharmaphorum

An FDA advisory committee has delivered a strong endorsement to Eli Lilly’s Alzheimer’s disease therapy donanemab, voting unanimously that the safety and efficacy of the amyloid-busting drug support its approval. The independent advisors on the Peripheral and Central Nervous System Drugs Advisory Committee voted by 11 to zero that donanemab’s benefits outweigh its risks, and by the same margin that the data submitted by Lilly to support its efficacy was convincing.

FDA 116
article thumbnail

AstraZeneca Tagrisso sNDA gains FDA priority review for lung cancer

Pharmaceutical Technology

AstraZeneca's sNDA for Tagrisso has obtained FDA priority review for unresectable, Stage III EGFRm non-small cell lung cancer.

FDA 111
article thumbnail

FDA clears Ipsen’s primary biliary cholangitis drug

pharmaphorum

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).

FDA 115
article thumbnail

Mount Sinai Medical Center Taps HealthSnap to Improve Chronic Conditions Management

MedCity News

South Florida-based Mount Sinai Medical Center announced a new remote patient monitoring and chronic care management partnership with HealthSnap, a Miami-based virtual care management platform. The partnership is aimed at improving outcomes among the health system’s Medicare population. The post Mount Sinai Medical Center Taps HealthSnap to Improve Chronic Conditions Management appeared first on MedCity News.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Purity, potency, and safety – affordably – in stem cell therapy

pharmaphorum

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh discusses stem cell therapy, and accessibility to and affordability of such treatment, with Rafael R Carazo Salas, founder and CEO of CellVoyant, an AI-first biotechnology company spun out from the University of Bristol.

Safety 112
article thumbnail

How Good Referral Pathways Impact Vascular and Overall Health

MedCity News

As with so many other conditions, in vascular health, patients often need to be seen within a few days or weeks, but current referral systems drag on for many weeks and months. The post How Good Referral Pathways Impact Vascular and Overall Health appeared first on MedCity News.

Patients 108
article thumbnail

UK pharma industry delivers election ‘wish list’

pharmaphorum

The Association of the British Pharmaceutical Industry (ABPI) is calling on political parties contesting the general election to spell out their plans to nurture and drive growth in the life sciences sector and deliver for patients.

Pharma 111
article thumbnail

US researchers develop AI liquid biopsy test to help identify lung cancer earlier

PharmaTimes

The leading cause of cancer globally accounts for an estimated 1.

Leads 107
article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

article thumbnail

ALZpath licenses Alzheimer’s diagnosis tech to Roche

pharmaphorum

Diagnostics giant Roche is putting its weight behind a biomarker for Alzheimer’s disease developed by ALZpath.

106
106
article thumbnail

LucyTx announces additional $12.5m research funding for neurological diseases

PharmaTimes

Alzheimer’s and Parkinson’s disease are responsible for more than 30 million cases globally

107
107
article thumbnail

GSK et al file appeal to Delaware Zantac order

pharmaphorum

GSK and other drugmakers have lost no time in filing an appeal to a Delaware court’s decision to allow more than 70,000 Zantac-related lawsuits to go ahead. Just over a week ago, Judge Vivian Medinilla of Delaware Superior Court issued an order ruling that cases claiming Zantac (ranitidine) could cause cancer were “admissible”, sparking a sell-off in GSK shares that wiped billions off its market cap.

Marketing 102
article thumbnail

A "Dashboard of Zero" for your Sales Pipeline

Clear Pivot

One of the best ways to find aging deals in your sales pipeline is to build a report that specifically highlights them. Here's how we do that in HubSpot.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

What Is Schema Markup for Healthcare & Why Is It Crucial for Modern SEO?

Healthcare Success

Schema markup is one of the levers that search engine optimization (SEO) specialists can leverage. Yet, it is surprisingly underutilized, making it an opportune way to increase your healthcare organization’s visibility on search engine results pages (SERPs). According to SEMRush, 92% of the top 10 results in Google Search incorporate schema markup. Although correlation does not equal causation, Google has mentioned in their documentation the importance of the correct schema to help improve their

article thumbnail

Syntegon Acquires Telstar

PharmaTech

Syntegon will expand its processing and packaging by acquiring the Spanish equipment supplier.

69
article thumbnail

As Big Pharma places bigger bets on ADCs, here’s where the field is headed next

PharmaVoice

With more drugmakers getting into the antibody-drug conjugate game, emerging innovations signal a bright future for the technology.

Pharma 59
article thumbnail

Kyowa Kirin invests $530m in new US biologics manufacturing facility

Pharmaceutical Technology

Kyowa Kirin has received approval from its board of directors to invest $530m to establish a new biologics plant in Sanford, NC, US.

article thumbnail

Signal-Based Selling: How to Leverage 4 Key Buying Signals

As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.

article thumbnail

Navigating the Deluge of Clinical Literature During and After COVID-19: Insights From ASHP Pharmacy Futures 2024

Pharmacy Times

Speakers at American Society of Health-System Pharmacists (ASHP) Pharmacy Futures 2024 discuss the significant increase in published clinical literature during and after the COVID-19 pandemic, and the evolving role and reliability of AI tools such as ChatGPT in providing accurate medical information.

Medical 55
article thumbnail

Strategies for Adapting Pharma Sales to Rural and Urban Markets in Alberta

Scott’s Directories

Navigating the diverse healthcare landscape of Alberta requires a strategic approach, particularly for pharmaceutical companies aiming to connect with medical professionals in both urban centers and rural areas. With a comprehensive list of doctors in Alberta at your disposal, you can tailor your outreach to meet the unique needs of various regions.

Sales 52
article thumbnail

Simplification of Continuous Tableting for Accelerated Product Development and Lifecycle Flexibility

PharmaTech

Webinar Date/Time: Wednesday, July 10, 2024 - 11am EDT | 4pm GMT | 5pm CEST

52
article thumbnail

Top 5 Doctor Lead Generation Strategies for Busy Sales Reps in Nova Scotia

Scott’s Directories

Navigating the healthcare landscape to connect with doctors can be challenging, especially for busy sales reps. In Nova Scotia, leveraging efficient strategies can make all the difference. Here, we discuss five top doctor lead generation strategies that will streamline your outreach and help you connect with healthcare professionals effectively. 1. Harness the Power of the Nova Scotia Doctors Directory One of the most effective tools at your disposal is the Nova Scotia Doctors Directory.

Doctors 52
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven